Literature DB >> 21934089

Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease.

Milton Packer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21934089     DOI： 10.1161/CIRCHEARTFAILURE.111.963710

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  20 in total

Review 1.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 2.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Bharathi Upadhya; George E Taffet; Che Ping Cheng; Dalane W Kitzman
Journal:  J Mol Cell Cardiol       Date:  2015-03-06       Impact factor: 5.000

3.  Update on heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; Dalane W Kitzman
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12

4.  Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.

Authors:  Robert Marcun; Ivan Stankovic; Radosav Vidakovic; Jerneja Farkas; Sasa Kadivec; Biljana Putnikovic; Ivan Ilic; Aleksandar N Neskovic; Mitja Lainscak
Journal:  Intern Emerg Med       Date:  2015-09-30       Impact factor: 3.397

5.  Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.

Authors:  Venkatesh Y Anjan; Timothy M Loftus; Michael A Burke; Nausheen Akhter; Gregg C Fonarow; Mihai Gheorghiade; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2012-06-07       Impact factor: 2.778

6.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Authors:  Muaz M Abudiab; Margaret M Redfield; Vojtech Melenovsky; Thomas P Olson; David A Kass; Bruce D Johnson; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

7.  Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Barry A Borlaug; Véronique L Roger; Sultan A Mirzoyev; Richard J Rodeheffer; Julio A Chirinos; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2012-10-17       Impact factor: 8.790

8.  Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

Review 9.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

Review 10.  What to Expect From the Evolving Field of Geriatric Cardiology.

Authors:  Susan P Bell; Nicole M Orr; John A Dodson; Michael W Rich; Nanette K Wenger; Kay Blum; John Gordon Harold; Mary E Tinetti; Mathew S Maurer; Daniel E Forman
Journal:  J Am Coll Cardiol       Date:  2015-09-15       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.